The peroxisome proliferator-activated receptor alpha (PPARalpha): role in hepatocarcinogenesis.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Molecular and Cellular Endocrinology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 12161004
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Progress in cardiovascular biology: PPAR for the course

  2001cited by this paper
• The pleiotropic functions of peroxisome proliferator-activated receptor γ

  2001cited by this paper
• The Peroxisome Proliferator-activated Receptor δ Promotes Lipid Accumulation in Human Macrophages*

  2001cited by this paper
• Human peroxisome proliferator-activated receptor alpha (PPARalpha) supports the induction of peroxisome proliferation in PPARalpha-deficient mouse liver.

  2001cited by this paper
• Tumor necrosis factor alpha is not required for WY14,643-induced cell proliferation.

  2001cited by this paper
• Peroxisome proliferators do not increase DNA synthesis in purified rat hepatocytes.

  2001cited by this paper
• Identification of Peroxisome Proliferator-responsive Human Genes by Elevated Expression of the Peroxisome Proliferator-activated Receptor α in HepG2 Cells*

  2001cited by this paper
• Peroxisome proliferator-activated receptor gamma and metabolic disease.

  2001cited by this paper
• Stimulatory effect of clofibrate on the action of estradiol in the mammary gland but not in the uterus of rats.

  2001cited by this paper
• Phthalates rapidly increase production of reactive oxygen species in vivo: role of Kupffer cells.

  2001cited by this paper
• Role of cytokines in non-genotoxic hepatocarcinogenesis: cause or effect?

  2001cited by this paper
• Genetic disruption of PPARdelta decreases the tumorigenicity of human colon cancer cells.

  2001cited by this paper
• Stimulatory effect of clofibrate and gemfibrozil administration on the formation of fatty acid esters of estradiol by rat liver microsomes.

  2001cited by this paper
• A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport

  2001cited by this paper
• Hepatocellular proliferation in response to a peroxisome proliferator does not require TNFalpha signaling.

  2001cited by this paper
• PPARalpha-dependent induction of liver microsomal esterification of estradiol and testosterone by a prototypical peroxisome proliferator.

  2001cited by this paper
• PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation

  2001cited by this paper
• Potential roles of the peroxisome proliferator-activated receptor-gamma in macrophage biology and atherosclerosis.

  2001cited by this paper
• A dominant negative form of IKK2 prevents suppression of apoptosis by the peroxisome proliferator nafenopin.

  2000cited by this paper
• Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer.

  2000cited by this paper
• PPAR-gamma agonists: therapeutic role in diabetes, inflammation and cancer.

  2000cited by this paper
• PPAR delta functions as a prostacyclin receptor in blastocyst implantation.

  2000cited by this paper
• Role of Kupffer cells and oxidants in signaling peroxisome proliferator-induced hepatocyte proliferation.

  2000cited by this paper
• Growth, Adipose, Brain, and Skin Alterations Resulting from Targeted Disruption of the Mouse Peroxisome Proliferator-Activated Receptor β(δ)

  2000cited by this paper
• Expression of base excision repair enzymes in rat and mouse liver is induced by peroxisome proliferators and is dependent upon carcinogenic potency.

  2000cited by this paper
• Oxidants from nicotinamide adenine dinucleotide phosphate oxidase are involved in triggering cell proliferation in the liver due to peroxisome proliferators.

  2000cited by this paper
• PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway.

  2000cited by this paper
• The human peroxisome proliferator-activated receptor alpha gene: identification and functional characterization of two natural allelic variants.

  2000cited by this paper
• Species differences in response to diethylhexylphthalate: suppression of apoptosis, induction of DNA synthesis and peroxisome proliferator activated receptor alpha-mediated gene expression

  2000cited by this paper
• Peroxisome proliferator-activated receptor alpha is restricted to hepatic parenchymal cells, not Kupffer cells: implications for the mechanism of action of peroxisome proliferators in hepatocarcinogenesis.

  2000cited by this paper
• Apoptosis in cancer.

  2000cited by this paper
• Role of hepatic non-parenchymal cells in the response of rat hepatocytes to the peroxisome proliferator nafenopin in vitro.

  2000cited by this paper
• A truncated human peroxisome proliferator-activated receptor alpha splice variant with dominant negative activity.

  1999cited by this paper
• Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma.

  1999cited by this paper
• PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs.

  1999cited by this paper
• PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.

  1998cited by this paper
• Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans?

  1998cited by this paper
• Peroxisome proliferator activated receptor-alpha expression in human liver.

  1998cited by this paper
• Consensus for the use of fibrates in the treatment of dyslipoproteinemia and coronary heart disease. Fibrate Consensus Group.

  1998cited by this paper
• Role of peroxisome proliferator-activated receptor alpha in altered cell cycle regulation in mouse liver.

  1998cited by this paper
• PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL.

  1998cited by this paper
• In vivo hepatocyte proliferation is inducible through a TNF and IL-6-independent pathway

  1998cited by this paper
• Biological esterification of steroids.

  1998cited by this paper
• Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans?

  1998cited by this paper
• Molecular basis of non-responsiveness to peroxisome proliferators: the guinea-pig PPARalpha is functional and mediates peroxisome proliferator-induced hypolipidaemia.

  1998cited by this paper
• Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha).

  1998cited by this paper
• Risk Assessment of Inhaled Chloroform Based on Its Mode of Action

  1997cited by this paper
• Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643.

  1997cited by this paper
• Expression of the Peroxisome Proliferator-activated Receptor Gene Is Stimulated by Stress and Follows a Diurnal Rhythm (*)

  1996cited by this paper
• Identification of a Peroxisome Proliferator-responsive Element Upstream of the Human Peroxisomal Fatty Acyl Coenzyme A Oxidase Gene (*)

  1996cited by this paper
• Mechanisms of estrogen-associated carcinogenesis.

  1996cited by this paper
• Hypomethylation of DNA: a nongenotoxic mechanism involved in tumor promotion.

  1995cited by this paper
• Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators

  1995cited by this paper
• Alterations in DNA methylation may play a variety of roles in carcinogenesis.

  1995cited by this paper
• Transformation of mammalian cells by overexpressing H2O2-generating peroxisomal fatty acyl-CoA oxidase.

  1995cited by this paper
• Differential expression and activation of a family of murine peroxisome proliferator-activated receptors.

  1994cited by this paper
• Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators.

  1994cited by this paper
• cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor.

  1993cited by this paper
• Differences in the steady‐state levels of c‐fos, c‐jun and c‐myc messenger RNA during mitogen‐induced liver growth and compensatory regeneration

  1993cited by this paper
• Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver.

  1993cited by this paper
• Lack of comitogenicity by the peroxisome proliferator hepatocarcinogens, Wy-14,643 and clofibric acid.

  1993cited by this paper
• Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors.

  1992cited by this paper
• Cloning of novel members of the steroid hormone receptor superfamily.

  1991cited by this paper
• No measurable increase in thymidine glycol or 8-hydroxydeoxyguanosine in liver DNA of rats treated with nafenopin or choline-devoid low-methionine diet.

  1990cited by this paper
• Oxidative DNA damage caused by persistent peroxisome proliferation: its role in hepatocarcinogenesis.

  1989cited by this paper
• Formation of 8-hydroxydeoxyguanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator.

  1989cited by this paper
• Biochemical mechanisms of induction of hepatic peroxisome proliferation.

  1989cited by this paper
• Morphometric study of human hepatic cell modifications induced by fenofibrate.

  1987cited by this paper
• Peroxisome proliferation due to di(2-ethylhexyl) phthalate (DEHP): species differences and possible mechanisms.

  1986cited by this paper
• The interaction of C-17 esters of estradiol with the estrogen receptor.

  1984cited by this paper
• Relationship between morphological changes and lipid-lowering action of p-chlorphenoxyisobutyric acid (CPIB) on hepatic mitochondria and peroxisomes in man.

  1983cited by this paper
• Influence of fenofibrate on cellular and subcellular liver structure in hyperlipidemic patients.

  1983cited by this paper
• Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans.

  1983cited by this paper
• Light and electron microscopy of liver in hyperlipoproteinemic patients under long-term gemfibrozil treatment.

  1982cited by this paper

• Effect of Leucine-enkephalin on Lipid Deposition and GSK-3β/mTOR Signaling in the Liver of Zebrafish

  2023cites this paper
• Identifying chemicals based on receptor binding/bioactivation/mechanistic explanation associated with potential to elicit hepatotoxicity and to support structure activity relationship-based read-across

  2023cites this paper
• Fenofibrate impairs liver function and structure more pronounced in old than young rats.

  2020cites this paper
• Inverse Association of Fibrates and Liver Cancer: A Population‐Based Case‐Control Study in Taiwan

  2019cites this paper
• Impaired T cell-mediated hepatitis in peroxisome proliferator activated receptor alpha (PPARα)-deficient mice

  2018cites this paper
• The whole transcriptome effects of the PPARα agonist fenofibrate on livers of hepatocyte humanized mice

  2018cites this paper
• Characterization of FoxO 3 in ROS and DNA damage-induced hepatocellular carcinoma

  2017cites this paper
• Alpha-fetoprotein-targeted reporter gene expression imaging in hepatocellular carcinoma.

  2016cites this paper
• Role of nuclear receptors in breast cancer stem cells.

  2016cites this paper
• Host nucleotide polymorphism in hepatitis B virus-associated hepatocellular carcinoma.

  2016cites this paper
• Exploiting microRNA and mRNA profiles generated in vitro from carcinogen-exposed primary mouse hepatocytes for predicting in vivo genotoxicity and carcinogenicity.

  2016cites this paper
• Peroxisome proliferator-activated receptor alpha deficiency impairs regulatory T cell functions: Possible application in the inhibition of melanoma tumor growth in mice.

  2016cites this paper
• The therapeutic applications of celery oil seed extract on the plasticizer di(2-ethylhexyl) phthalate toxicity

  2015cites this paper
• Effects of the PPARα agonist WY-14,643 on plasma lipids, enzymatic activities and mRNA expression of lipid metabolism genes in a marine flatfish, Scophthalmus maximus.

  2015cites this paper
• Effects of clofibric acid alone and in combination with 17β-estradiol on mRNA abundance in primary hepatocytes isolated from rainbow trout.

  2014cites this paper
• Regulation of energy metabolism by long-chain fatty acids.

  2014cites this paper
• Integrated physiology and systems biology of PPARα

  2014cites this paper
• Generation of liver-specific TGF-α and c-Myc-overexpressing fibroblasts for future creation of a liver cancer porcine model.

  2014cites this paper
• Distinguishing between genotoxic and non-genotoxic hepatocarcinogens by gene expression profiling and bioinformatic pathway analysis

  2013cites this paper
• Tissue expression of PPAR-alpha isoforms in Scophthalmus maximus and transcriptional response of target genes in the heart after exposure to WY-14643

  2013cites this paper
• Comparative gene expression profiles induced by PPARγ and PPARα/γ agonists in rat hepatocytes.

  2011cites this paper
• Fatty acid omega‐oxidation as a rescue pathway for fatty acid oxidation disorders in humans

  2011cites this paper
• Inflammatory Mediators and Insulin Resistance in Obesity: Role of Nuclear Receptor Signaling in Macrophages

  2010cites this paper
• Fenofibrate induces effective apoptosis in mantle cell lymphoma by inhibiting the TNFα/NF-κB signaling axis

  2010cites this paper
• Be different--the diversity of peroxisomes in the animal kingdom.

  2010cites this paper
• A Preliminary Operational Classification System for Nonmutagenic Modes of Action for Carcinogenesis

  2009influential citation
• A preliminary operational classification system for nonmutagenic modes of action for carcinogenesis.

  2009influential citation
• Comprehensive analysis of hepatic gene and protein expression profiles on phenobarbital- or clofibrate-induced hepatic hypertrophy in dogs.

  2009cites this paper
• Clinically relevant concentrations of di (2-ethylhexyl) phthalate (DEHP) uncouple cardiac syncytium.

  2009cites this paper
• Epigenetic inhibition of nuclear receptor small heterodimer partner is associated with and regulates hepatocellular carcinoma growth.

  2008cites this paper
• PPAR-alpha L162V polymorphism in human hepatocellular carcinoma.

  2008cites this paper
• Gene Expression–Based Recurrence Prediction of Hepatitis B Virus–Related Human Hepatocellular Carcinoma

  2008cites this paper
• Mouse models in liver cancer research: a review of current literature.

  2008cites this paper
• Inhibiting wild-type and C299S mutant AKR1B10; a homologue of aldose reductase upregulated in cancers.

  2008cites this paper
• Nrf2- and PPAR alpha-mediated regulation of hepatic Mrp transporters after exposure to perfluorooctanoic acid and perfluorodecanoic acid.

  2008cites this paper
• PPARα Ligands as Antitumorigenic and Antiangiogenic Agents

  2008cites this paper
• Peroxisome proliferators-activated alpha agonist treatment ameliorates hepatic damage in rats with obstructive jaundice: an experimental study

  2007cites this paper
• PPAR\(\alpha\) Deficiency in Inflammatory Cells Suppresses Tumor Growth

  2007influential citation
• PPARα Deficiency in Inflammatory Cells Suppresses Tumor Growth

  2007influential citation
• New insights in phytanic acid metabolism and toxicity

  2007cites this paper
• Chemistory of Fibrates.

  2007cites this paper
• Differential regulation of the cynomolgus, human, and rat acyl-CoA oxidase promoters by PPARalpha.

  2006cites this paper
• Cytochrome P450 and xenobiotic receptor humanized mice.

  2006cites this paper
• Peroxisome proliferator-activated receptor alpha is required for feedback regulation of highly unsaturated fatty acid synthesis.

  2005cites this paper
• A phytol-enriched diet induces changes in fatty acid metabolism in mice both via PPARalpha-dependent and -independent pathways.

  2005cites this paper
• Gene expression profiling of the PPAR-alpha agonist ciprofibrate in the cynomolgus monkey liver.

  2005cites this paper
• Gene ontology mapping as an unbiased method for identifying molecular pathways and processes affected by toxicant exposure: application to acute effects caused by the rodent non-genotoxic carcinogen diethylhexylphthalate.

  2005influential citation
• Induction of overlapping genes by fasting and a peroxisome proliferator in pigs: evidence of functional PPARalpha in nonproliferating species.

  2005cites this paper
• Role of Oxidative Stress in Peroxisome Proliferator-Mediated Carcinogenesis

  2005cites this paper
• Nutrigenomic approach to understanding the mechanisms by which dietary long-chain fatty acids induce gene signals and control mechanisms involved in carcinogenesis.

  2004cites this paper
• Nutrient-gene interactions: a single nutrient and hundreds of target genes

  2004cites this paper
• Genomic and non-genomic interactions of PPARalpha with xenobiotic-metabolizing enzymes.

  2004cites this paper
• Visualization and quantitation of peroxisomes using fluorescent nanocrystals: treatment of rats and monkeys with fibrates and detection in the liver.

  2004cites this paper
• Profiling of hepatic gene expression in rats treated with fibric acid analogs.

  2004cites this paper
• Liver gene expression in rats in response to the peroxisome proliferator-activated receptor-alpha agonist ciprofibrate.

  2003cites this paper
• Peroxisome proliferator-activated receptors, fatty acid oxidation, steatohepatitis and hepatocarcinogenesis.

  2003cites this paper